1. The Use of Statins and Lung Function in Current and Former Smokers
Keddissi Jean I. , MD, FCCP, Younis Walid G. , MD, Chbeir Elie A. , MD, Daher Nadim N. , MD, Dernaika Tarek A. , MD, Kinasewitz Gary T. , MD, FCCP 
CHEST 
Volume 132, Issue 6, Pages (December 2007)
DOI: /chest
Copyright © 2007 The American College of Chest Physicians Terms and Conditions

2. Figure 1
Effect on statin use on FEV1 decline in the smokers and ex-smokers groups. Data are presented as mean ± SEM. Negative values denote an increase in FEV1. *p < for statin vs control in the smokers group, and p < in the ex-smokers group.
CHEST  , DOI: ( /chest )
Copyright © 2007 The American College of Chest Physicians Terms and Conditions

3. Figure 2
Effect on statin use on FVC decline in the smokers and ex-smokers groups. Data are presented as mean ± SEM. Negative values denote an increase in FVC. *p = 0.01 for statin vs control in the smokers group, and p < in the ex-smokers group.
CHEST  , DOI: ( /chest )
Copyright © 2007 The American College of Chest Physicians Terms and Conditions

4. Figure 3
Effect on statin use on FEV1 decline in the obstructive and restrictive spirometry groups. Data are presented as mean ± SEM. Negative values denote an increase in FEV1. *p < for statin vs control in the obstructive group, and p < in the restrictive group.
CHEST  , DOI: ( /chest )
Copyright © 2007 The American College of Chest Physicians Terms and Conditions

5. Figure 4
Effect on statin use on FVC decline in the obstructive and restrictive spirometry groups. Data are presented as mean ± SEM. Negative values denote an increase in FVC. *p < for statin vs control in the obstructive group, and p = in the restrictive group.
CHEST  , DOI: ( /chest )
Copyright © 2007 The American College of Chest Physicians Terms and Conditions